<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Trop. Med. Hyg</journal-id>
      <journal-id journal-id-type="publisher-id">tpmd</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9637</issn>
      <issn pub-type="epub">1476-1645</issn>
      <publisher>
        <publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26251526</article-id>
      <article-id pub-id-type="pmc">4530734</article-id>
      <article-id pub-id-type="doi">10.4269/ajtmh.14-0491</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Images in Clinical Tropical Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man</article-title>
        <alt-title alt-title-type="left-running">FU AND OTHERS</alt-title>
        <alt-title alt-title-type="right-running">BORDERLINE LEPROMATOUS LEPROSY</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>Xi&#x2019;an</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Hong</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Furen</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="AFF1">Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Shandong, People&#x2019;s Republic of China; Shandong Provincial Hospital for Skin Diseases, Shandong University, Shandong, People&#x2019;s Republic of China</aff>
      <author-notes>
        <corresp id="COR1">*Address correspondence to Furen Zhang, 27397 Jingshi Lu, Jinan 250022, Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Shandong Province, People&#x2019;s Republic of China. E-mail: <email>zhangfuren@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>05</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>05</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <volume>93</volume>
      <issue>2</issue>
      <fpage>207</fpage>
      <lpage>209</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;The American Society of Tropical Medicine and Hygiene</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>A 59-year-old man diagnosed with borderline lepromatous leprosy developed reddish patches and plaques on the face, which progressively enlarged and spread to the trunk and limbs (<xref ref-type="fig" rid="F1">Figure 1A</xref>&#x2013;<xref ref-type="fig" rid="F1">D</xref>
<fig id="F1" position="float"><label>Figure 1.</label><caption><p>Pre-therapy clinical photograph showing reddish patches and plaques appeared on the patient&#x2019;s face (<bold>A</bold>), elbow (<bold>B</bold>), knee (<bold>C</bold>), and buttock (<bold>D</bold>).</p></caption><graphic xlink:href="tropmed-93-207-g001"/></fig>). Other superficial nerves appeared normal. Biopsy showed plasmocytic and lymphocytic infiltration in the nerve tract, and was 4+ acid-fast bacilli (AFB)&#x2013;stain positive suggesting <italic>Mycobacterium leprae</italic> (<xref ref-type="fig" rid="F2">Figure 2A</xref> and <xref ref-type="fig" rid="F2">B</xref>
<fig id="F2" position="float"><label>Figure 2.</label><caption><p>Pre-therapy histopathologic analysis showing (left leg): (<bold>A</bold>) plasmocytic and lymphocytic infiltration surrounding dermal nerve and Schwann cells and inflammatory cell infiltrated into nerve tract (Hematoxylin and Eeosin [H&amp;E] staining &#xD7;400), and (<bold>B</bold>) positive staining for lepra bacilli (4+) (acid-fast bacilli [AFB] stain).</p></caption><graphic xlink:href="tropmed-93-207-g002"/></fig>); this was confirmed by real-time polymerase chain reaction (PCR). The HLA-B*13:01 test was negative. Two weeks after rifampin, dapsone, and clofazimine (World Health Organization multidrug therapy [WHO MDT] regimen) were started, the skin lesions (hypochromic macules) became red, edematous, and enlarged (<xref ref-type="fig" rid="F3">Figure 3A</xref>&#x2013;<xref ref-type="fig" rid="F3">D</xref>
<fig id="F3" position="float"><label>Figure 3.</label><caption><p>Post-therapy clinical photograph (2 weeks after initiation of multidrug therapy [MDT]). The preexisting lesions in the form of hypochromic macules turned red, edematous, squamous, enlarged, and the inflammatory infiltration aggravated, face (<bold>A</bold>), knee (<bold>B</bold>), elbow (<bold>C</bold>), and buttock (<bold>D</bold>).</p></caption><graphic xlink:href="tropmed-93-207-g003"/></fig>). Both ulnar nerves became tender and thickened; ultrasonography showed reduction of blood flow (<xref ref-type="fig" rid="F4">Figure 4A</xref> and <xref ref-type="fig" rid="F4">B</xref>
<fig id="F4" position="float"><label>Figure 4.</label><caption><p>Post-therapy (2 weeks after initiation of multidrug therapy [MDT]) ultrasonography and color Doppler images of peripheral nerve of the patient. (<bold>A</bold>) Cross-section scan of the right side ulnar nerve with hypoechoic fascicles: 0.889 cm at its widest point and (<bold>B</bold>) abnormal blood flow signals around the right ulnar nerve.</p></caption><graphic xlink:href="tropmed-93-207-g004"/></fig>). Collectively these findings indicated a type 1 conversion reaction (T1R) (<xref ref-type="fig" rid="F2">Figure 2C</xref>). One year after prednisone was started (40 mg/day for 3 months with progressive tapering), the T1R was found to be completely resolved.</p>
    <p>In leprosy, type 1 and type 2 reactions&#x2014;whether spontaneous or related to treatment&#x2014;are the main causes of morbidity. T1Rs result from cell-mediated immunity affecting up to 30% of susceptible individuals.<xref rid="R1" ref-type="bibr">1</xref> Nonpolar forms of leprosy are the primary risk factor for the occurrence of T1Rs.<xref rid="R2" ref-type="bibr">2</xref> Systemic corticosteroids remain the mainstay of treatment of T1Rs.</p>
  </body>
  <back>
    <fn-group>
      <fn id="FN1" fn-type="present-address">
        <p>Authors&#x2019; addresses: Xi&#x2019;an Fu, Hong Liu, and Furen Zhang, Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Shandong, People&#x2019;s Republic of China, and Shandong Provincial Hospital for Skin Diseases, Shandong University, Shandong, People&#x2019;s Republic of China, E-mails: <email>f19830827@126.com</email>, <email>hongyue2519@hotmail.com</email>, and <email>zhangfuren@hotmail.com</email>.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1.</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Walker</surname><given-names>SL</given-names></name><name><surname>Lockwood</surname><given-names>DN</given-names></name></person-group>
<year>2008</year>
<article-title>Leprosy type 1 (reversal) reactions and their management</article-title>
<source>Lepr Rev</source>
<volume>79</volume>
<fpage>372</fpage>
<lpage>386</lpage><pub-id pub-id-type="pmid">19274984</pub-id></element-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nery</surname><given-names>JA</given-names></name><name><surname>Bernardes Filho</surname><given-names>F</given-names></name><name><surname>Quintanilha</surname><given-names>J</given-names></name><name><surname>Machado</surname><given-names>AM</given-names></name><name><surname>Oliveira Sde</surname><given-names>S</given-names></name><name><surname>Sales</surname><given-names>AM</given-names></name></person-group>
<year>2013</year>
<article-title>Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy</article-title>
<source>An Bras Dermatol</source>
<volume>88</volume>
<fpage>787</fpage>
<lpage>792</lpage><pub-id pub-id-type="pmid">24173185</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
